These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 35597610)

  • 1. From cryptogenic to ESUS: Toward precision medicine?
    Timsit S
    Rev Neurol (Paris); 2022 Nov; 178(9):939-952. PubMed ID: 35597610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipsilateral Carotid Plaque Presence is Inversely Associated with Patent Foramen Ovale in Cryptogenic Stroke: A Multicenter CohortStudy.
    Sathya A; Nguyen TN; Reyes-Esteves S; Kamen S; Hester T; Vigilante N; Woo J; Zhang L; Abdalkader M; Cucchiara B; Siegler JE
    J Stroke Cerebrovasc Dis; 2022 Aug; 31(8):106606. PubMed ID: 35749935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
    Diener HC; Wachter R; Wong A; Thijs V; Schnabel RB; Ntaios G; Kasner S; Rothwell PM; Passman R; Saver JL; Albers BA; Bernstein RA
    Int J Stroke; 2023 Apr; 18(4):400-407. PubMed ID: 36050817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Risk of Paradoxical Embolism Score Validation and Atrial Fibrillation Prediction.
    Strambo D; Sirimarco G; Nannoni S; Perlepe K; Ntaios G; Vemmos K; Michel P
    Stroke; 2021 May; 52(5):1643-1652. PubMed ID: 33784832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unique Clinicopathologic Subclassifiers of Cryptogenic Cerebral Emboli.
    Siegler JE; Thau L; Hester T; Yeager T; Vigilante N; Kamen S; Heslin M; Shannon R; Zhang L; Butler M; Higham C; Oak S; Wolfe J; Patel P; Patel P; Thon JM
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106427. PubMed ID: 35279004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source: The Young ESUS Longitudinal Cohort Study.
    Perera KS; de Sa Boasquevisque D; Rao-Melacini P; Taylor A; Cheng A; Hankey GJ; Lee S; Fabregas JM; Ameriso SF; Field TS; Arauz A; Coutts SB; Arnold M; Mikulik R; Toni D; Mandzia J; Veltkamp RC; Meseguer E; Haeusler KG; Hart RG;
    JAMA Neurol; 2022 May; 79(5):450-458. PubMed ID: 35285869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of Infratentorial Lesion could Predict Patent Foramen Ovale as an Etiology in Embolic Stroke of Undetermined Source.
    Ishizuka K; Toi S; Hoshino T; Higuchi E; Kitagawa K
    J Atheroscler Thromb; 2022 May; 29(5):785-793. PubMed ID: 33952811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Approach to Working Up Cases of Embolic Stroke of Undetermined Source.
    Ryoo S; Chung JW; Lee MJ; Kim SJ; Lee JS; Kim GM; Chung CS; Lee KH; Hong JM; Bang OY
    J Am Heart Assoc; 2016 Mar; 5(3):e002975. PubMed ID: 27006118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
    Diener HC; Chutinet A; Easton JD; Granger CB; Kleine E; Marquardt L; Meyerhoff J; Zini A; Sacco RL
    Stroke; 2021 Mar; 52(3):1065-1068. PubMed ID: 33504190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catch-up-ESUS - follow-up in embolic stroke of undetermined source (ESUS) in a prospective, open-label, observational study: study protocol and initial baseline data.
    Feil K; Heinrich J; Küpper C; Müller K; Laub C; von Falkenhausen AS; Becker R; Wollenweber FA; Kääb S; Sinner MF; Kellert L
    BMJ Open; 2019 Dec; 9(12):e031716. PubMed ID: 31822542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis.
    Ntaios G; Papavasileiou V; Milionis H; Makaritsis K; Manios E; Spengos K; Michel P; Vemmos K
    Stroke; 2015 Jan; 46(1):176-81. PubMed ID: 25378429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embolic infarct topology differs between atrial fibrillation subtypes and embolic stroke of undetermined source.
    Wolfe J; Oak S; Tiongson J; Vigilante N; Frost E; Penckofer M; Thau L; Iezzi Z; Patel P; Siegler JE
    J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106782. PubMed ID: 36130470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent foramen ovale closure in the management of cryptogenic stroke: a review of current literature and guideline statements.
    Elzanaty AM; Patel N; Sabbagh E; Eltahawy EA
    Curr Med Res Opin; 2021 Mar; 37(3):377-384. PubMed ID: 33460329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolic stroke of undetermined source: Focusing on atrial cardiopathy and patent foramen ovale.
    Zhang M; Xiao Q; Wang K; Yin R; Liu G; Zhao H; Li P; Zhu X; Pan X
    Int J Cardiol; 2024 May; 402():131810. PubMed ID: 38272131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ESUS (embolic stroke of undetermined sources)].
    Kitagawa K
    Nihon Rinsho; 2016 Apr; 74(4):597-602. PubMed ID: 27333746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
    Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
    J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
    Kasner SE; Swaminathan B; Lavados P; Sharma M; Muir K; Veltkamp R; Ameriso SF; Endres M; Lutsep H; Messé SR; Spence JD; Nedeltechev K; Perera K; Santo G; Olavarria V; Lindgren A; Bangdiwala S; Shoamanesh A; Berkowitz SD; Mundl H; Connolly SJ; Hart RG;
    Lancet Neurol; 2018 Dec; 17(12):1053-1060. PubMed ID: 30274772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid Atherosclerosis and Patent Foramen Ovale in Embolic Stroke of Undetermined Source.
    Ntaios G; Sagris D; Strambo D; Perlepe K; Sirimarco G; Georgiopoulos G; Nannoni S; Korompoki E; Manios E; Makaritsis K; Vemmos K; Michel P
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105409. PubMed ID: 33137616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cryptogenic cerebral infarction: from classification to concept].
    Timsit S; Breuilly C
    Presse Med; 2009 Dec; 38(12):1832-42. PubMed ID: 19395232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.